News

September 2023: European Research Council Proof of Concept award for cancer prevention research

Martin Widschwendter, Professor of Oncology and Prevention at the University of Innsbruck, has been awarded Proof of Concept funding from the European Research Council (ERC) for his pioneering work in preventive medicine. The new project is based on his ERC Advanced Grant and is intended to further exploit his work in cancer prevention.

August 2023: Using biomarkers to combat age-related diseases

Read our new publication in Cell in collaboration with the international Biomarkers of Aging Consortium.

May 2023: EUTOPS postdoctoral researcher Chiara Herzog receives the Ernst Brandl Prize

EUTOPS postdoctoral researcher Chiara Herzog has received the Ernst Brandl Prize of €4,000 for her work on the development and validation of a novel epigenetic test – the WID-qEC test – for the early detection of endometrial cancer. Chiara is an integral member of the EUTOPS team, working on computational aspects of epigenetics in cancer development and prevention and in ageing research.

February 2023: A new molecular test captures Human Papilloma Virus (HPV) induced changes in a woman’s epigenome

A new publication from Professor Martin Widschwendter and the EUTOPS team in the International Journal of Cancer describes the development of cervical cancer as a result of Human Papilloma Virus (HPV) infection.

February, October, and December 2022: Women’s cancer detection and risk prediction – four cancers, one test

The EUTOPS team presents four publications demonstrating that DNA methylation signature assessment using methylation array analysis in cervical screening samples detects and likely predicts the risk for all four major women’s cancers: breast, ovarian, womb and cervical cancer.

October 2022: New cervical screening test could predict cell changes years before they happen

A new publication from Professor Martin Widschwendter and the EUTOPS team in Genome Medicine describes a new molecular test that can identify 55% of those with a normal cervical smear result who will go on to develop advanced cell changes or cancer within 4 years.

September 2022: Tirol=Gesund

With the LIFE and SUN Tyrol studies, we are launching two large-scale investigations to test interval fasting, exercise and stress reduction for their health-promoting effects (LIFE Tyrol) and to optimize smoking cessation (SUN Tyrol).

August 2022: New molecular test proves reliable for early detection of womb cancer

Our paper describing a new test that accurately identifies women with womb cancer appears in Journal of Clinical Oncology today.

June 2022: Breast cancer prevention with antiprogestins and the WID-Breast29 index

Our paper describing individualised breast cancer prevention and risk monitoring using antiprogestins and the epigenetic WID-Breast29 index appears in Genome Medicine today.

February 2022: Publication of WID epigenetic clocks

Today we published the WID epigenetic clocks (WID-age and WID-relative epithelial age, WID-REA) in Genome Biology.

EUTOPS Institute

Our vision is to integrate cutting-edge research in systems biology and oncology to enable real-world implementation of the concepts of P4 medicine (predictive, preventive, personalised and participatory) and drastically reduce cancer mortality.

Meet the Team

We are a dynamic and international team with wide range of expertise.